|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 10/19/2017 1:14:59 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 1832, To authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention, all provisions
S. 834, To authorize the appropriation of funds to the Centers for Disease Control and Prevention for conducting or supporting research on firearms safety or gun violence prevention, all provisions
Comprehensive Addiction and Recovery Act (CARA) funding
Prescription Drug Monitoring Program (PDMP) funding
National Quality Forum (NQF) funding
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Andrew |
Wankum |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 309, National Clinical Care Commission Act, all provisions
S. 920, National Clinical Care Commission Act, all provisions
H.R. 1270, Living Donor Protection Act of 2017, all provisions
H.R. 3440, DREAM Act of 2017, all provisions
S. 1615, DREAM Act of 2017, all provisions
H.R. 394, Restoring Access to Medication Act of 2017, all provisions
S. 85, Restoring Access to Medication Act of 2017, all provisions
H.R. 1628, The American Health Care Act, all provisions and Graham-Cassidy amendment
S. 1803, Marijuana Effective Drug Studies (MEDS) Act of 2017, all provisions
H.R. 1057, Synthetics Trafficking and Overdose Prevention (STOP) Act of 2017, all provisions
S. 372, Synthetics Trafficking and Overdose Prevention (STOP) Act of 2017, all provisions
H.R. 2077, Restoring the Patient's Voice Act of 2017, all provisions
H.R. 2430, FDA Reauthorization Act of 2017, all provisions
S. 934, FDA Reauthorization Act of 2017, all provisions
S.1754 - Training the Next Generation of Primary Care Doctors Act of 2017, provisions relating to community health center fund reauthorization
H.R.3394 - Teaching Health Centers Graduate Medical Education (THCGME) Extension Act of 2017, provisions relating to community health center fund reauthorization
Better Care Reconciliation Act (BCRA), all provisions
Obamacare Repeal Reconciliation Act (ORRA), all provisions
The Healthcare Freedom Act, S. Amdt. 667
Affordable Care Act Repeal/Replace
Affordable Care Act: market stabilization; Section 1557
Comprehensive Addiction and Recovery Act (CARA) partial fill policies
Opioid Abuse
Medication-Assisted Treatment (MAT)
Immigration - DACA program
Travel Ban
Health Savings Accounts - Prescription requirement for over-the-counter medications
Health Care Reform
Regulatory Relief
Telemedicine
Technology-based Eye Care Services program
Prior authorization
Software as a Medical Device (SaMD)
National Evaluation System for Health Technology (NEST)
Mobile health apps
Electronic prescribing of controlled substances
Continuing Medical Education and opioid/pain management prescribing
Prescription Drug Pricing
Small practice/solo physician groups/FDA policies
Rural communities/broadband coverage expansion
National Service Fund cap
HIPAA: Section 1557, gender identity protection
Cybersecurity
Digital medicine
ICD-10
Hurricane Relief
Drug Compounding
Electronic Health Records (EHR) - interoperability, data blocking, certification
National Practitioner Data Bank (NPDB)
Nomination of Jerome Adams, MD for Surgeon General of the U.S.
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), President of the U.S., Health Resources & Services Administration (HRSA), U.S. Postal Service (USPS), Drug Enforcement Administration (DEA), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 898, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Medical Licensure
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 2556, CONNECT for Health Act of 2017, provisions relating to Medicare
S. 1016, CONNECT for Health Act of 2017, provisions relating to Medicare
S. 1827, Keep Kids' Insurance Dependable and Secure (KIDS) Act of 2017, provisions related to Childrens Health Insurance Program (CHIP) reauthorization
H.R. 3921, Helping Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable (HEALTHY KIDS) Act of 2017, provisions related to CHIP reauthorization
H.R. 2276, Audiology Patient Choice Act of 2017, all provisions
H.R. 1628, The American Health Care Act, provisions relating to Medicare and Medicaid
H.R. 3482, Evidence-Based Telehealth Expansion Act of 2017, all provisions
H.R. 2938, Road to Recovery Act, all provisions
H.R. 849, Protecting Seniors' Access to Medicare Act of 2017, all provisions
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, all provisions
H.R. 1156, Patient Access to Higher Quality Health Care Act of 2017, all provisions
S. 1133, Patient Access to Higher Quality Health Care Act of 2017, all provisions
H.R. 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests, all provisions
S. 479, Removing Barriers to Colorectal Cancer Screening Act of 2017, all provisions
H.R. 3528, Every Prescription Conveyed Securely Act, all provisions
Medicare program: Better Care Reconciliation Act (BCRA), provisions relating to Medicaid
Medicare program: Obamacare Repeal Reconciliation Act (ORRA), provisions relating to Medicaid
Medicare program: Medicare Common Access Card Act, provisions relating to fraud
Medicare program: Independent Payment Advisory Board (IPAB) repeal
Medicare program: Protecting Access to Medicare Act (PAMA) implementation/clinical labs
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: Misvalued codes
Medicare program: Small group practice definition
Medicare program: Physician-Focused Payment Model Technical Advisory Committee (PTAC) technical assistance
Medicare program: Creating Access to Residency Education Act, all provisions
Medicare program: MACRA implementation
Medicare program: MACRA modifications
Medicare program: Electronic Health Records (EHR)
Medicare program: Alternate Payment Models (APM)
Medicare program: Graduate Medical Education
Medicare program: Regulatory Relief
Medicare program: Telemedicine
Medicare program: Quality Payment Program (QPP)
Medicare program: Physician Quality Reporting System
Medicare program: Value-Based Modifier (VBM)
Medicare program: Medicare Advantage
Medicare program: Two-Midnight/Observation Care
Medicare program: Appropriate Use Criteria
Medicare program: Evaluation and Management (E&M) documentation guidelines
Medicare program: Office of the National Coordinator (ONC) Health IT Certification
Medicare program: Unique Device Identifier (UDI)
Medicare program: Medical home models flexibility
Medicare program: All-Cause Hospital Readmissions Measure
Medicare program: Prior authorization
Medicare program: Electronic prescribing of controlled substances
Medicare program: Pharmacy Benefit Manager (PBM)
Medicare program: Meaningful Use (MU)/Advancing Care Information (ACI) scoring system
Medicare program: Program Integrity
Medicare program: Provider interpretation and translation services costs
Medicare program: Institutions for Mental Diseases (IMD) exclusion
Medicare program: Medicaid Reform
Medicare program: Open Payments
Medicare program: Provider Enrollment, Chain & Ownership System (PECOS)/Medicare Enrollment
Medicare program: Diabetes Prevention
Medicare program: HIPAA: Section 1557, gender identity protection
Medicare program: Interoperability and Trust Framework
Medicare program: Electronic attachments
Medicare program: ICD-10
Medicare program: Audits
Medicare and Medicaid programs: AAHPMs HHS/PTAC proposal for Patient and Caregiver Support for Serious Illness (PACSSI) payment model
Medicare and Medicaid programs: Stark Law reforms
Medicaid program: Childrens Health Insurance Program (CHIP)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), President of the U.S., Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Ashley |
McGlone |
|
|
|
Kristen |
O'Brien |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Tax Reform - Accounting Methods
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 302, Sports Medicine Licensure Clarity Act of 2017, all provisions
S. 808, Sports Medicine Licensure Clarity Act of 2017, all provisions
H.R. 1215, Protecting Access to Care Act of 2017, all provisions
H.R. 1876, Good Samaritan Health Professionals Act of 2017, all provisions
H.R. 1704, Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act of 2017, all provisions
Medical Liability Reform
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
S. 925, Veterans E-Health and Telemedicine Support Act of 2017, all provisions
VA Choice Program Reauthorization
Telehealth
Scope of Practice
17. House(s) of Congress and Federal agencies Check if None
Veterans Affairs - Dept of (VA), U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
TOB |
CSP |
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |